For the ERCC1 gene, the defective ERCC1 gene could increase the incidence of vascular diseases [35], and genetic polymorphisms of ERCC1 could affect the efficiency of chemotherapy, as well as the susceptibility of a variety of diseases, including lung cancer and several cardiovascular diseases [36,37,38]. The gene discussed is ERCC1; the disease is lung cancer.